Found: 17
Select item for more details and to access through your institution.
Methodological aspects of health‐related quality of life measurement and analysis in patients with multiple myeloma.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 11, doi. 10.1111/bjh.15759
- By:
- Publication type:
- Article
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population‐based study from the Danish national multiple myeloma registry
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 119, doi. 10.1111/bjh.16806
- By:
- Publication type:
- Article
Methodological aspects of health‐related quality of life measurement and analysis in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 11, doi. 10.1111/bjh.15759
- By:
- Publication type:
- Article
A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0110-0
- By:
- Publication type:
- Article
Health-related quality of life in patients with multiple myeloma participating in a multidisciplinary rehabilitation program.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2311, doi. 10.1007/s00277-020-04356-0
- By:
- Publication type:
- Article
The impact of changed treatment patterns in multiple myeloma on health‐care utilisation and costs, myeloma complications, and survival: A population‐based comparison between two time periods in Denmark.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 63, doi. 10.1111/ejh.13615
- By:
- Publication type:
- Article
Clarithromycin added to bortezomib‐cyclophosphamide‐dexamethasone impairs health‐related quality of life in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 1, p. 70, doi. 10.1111/ejh.13175
- By:
- Publication type:
- Article
A systematic review of health-related quality of life in longitudinal studies of myeloma patients.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 1, p. 3, doi. 10.1111/ejh.12882
- By:
- Publication type:
- Article
A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e279, doi. 10.1016/j.clml.2019.09.460
- By:
- Publication type:
- Article
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Transition of care in a Danish context: translation, cross-cultural adaptation and content validation of CTM-15 and PACT-M.
- Published in:
- Journal of Patient-Reported Outcomes, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41687-024-00739-3
- By:
- Publication type:
- Article
Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
- Published in:
- Journal of Patient-Reported Outcomes, 2024, v. 8, p. 1, doi. 10.1186/s41687-024-00691-2
- By:
- Publication type:
- Article
Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study.
- Published in:
- Oncology Nursing Forum, 2023, v. 50, n. 5, p. 635, doi. 10.1188/23.ONF.635-645
- By:
- Publication type:
- Article
Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.
- Published in:
- Quality of Life Research, 2024, v. 33, n. 9, p. 2387, doi. 10.1007/s11136-024-03707-y
- By:
- Publication type:
- Article
Unsupervised item response theory models for assessing sample heterogeneity in patient-reported outcomes measures.
- Published in:
- Quality of Life Research, 2024, v. 33, n. 3, p. 853, doi. 10.1007/s11136-023-03560-5
- By:
- Publication type:
- Article
Implications of response shift for micro-, meso-, and macro-level healthcare decision-making using results of patient-reported outcome measures.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 12, p. 3343, doi. 10.1007/s11136-021-02766-9
- By:
- Publication type:
- Article
Strategies to improve patient-reported outcome completion rates in longitudinal studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article